Received Dec 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 3EG9B | IM / RA |
PATIENT REPORTED DEVELOPING (2-2.5 WEEKS POST VACCINATION) A RASH WITH BLISTERS AND INTENSE ITCHING. SHE ALSO STATED THAT THE TEXTURE OF HER SKIN CHANGED. AT THE TIME OF REPORTING, SHE INFORMED ME THAT THIS ALSO OCCURRED WITH THE FIRST DOSE. SHE DID SEEK MEDICAL ATTENTION WITH HER PRIMARY CARE DOCTOR AFTER THE FIRST REACTION. THE PATIENT STATED THE DOCTOR DID NOT SEEMED CONCERNED AND INSISTED SHE GET THE SECOND DOSE WHEN IT WAS DUE. THE PATIENT REPORTED THAT SHE USED CALAMINE LOTION FOR RELIEF AND THAT SHE HAS RECOVERED FROM THE EVENT AT THE TIME OF REPORTING WHICH WAS ABOUT 2 MONTHS POST VACCINATION WITH THE SECOND DOSE.
NONE REPORTED
HIGH COLESTEROL, ATRIAL FIBRILLATION, GERD
REPATHA INJECTION, ELIQUIS, METOPROLOL, PANTOPRAZOLE, ESTRADIOL, FLUTICASONE NASAL SPRAY
LATEX
NONE REPORTED
SHINGLES DOSE 1 ON 7/17/25, BUT NOT REPORTED UNTIL NOW